Cargando…
Identification of autism-related MECP2 mutations by whole-exome sequencing and functional validation
BACKGROUND: Methyl-CpG-binding protein-2 (MeCP2) is a critical regulator for neural development. Either loss- or gain-of-function leads to severe neurodevelopmental disorders, such as Rett syndrome (RTT) and autism spectrum disorder (ASD). We set out to screen for MECP2 mutations in patients of ASD...
Autores principales: | Wen, Zhu, Cheng, Tian-Lin, Li, Gai-zhi, Sun, Shi-Bang, Yu, Shun-Ying, Zhang, Yi, Du, Ya-Song, Qiu, Zilong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5543534/ https://www.ncbi.nlm.nih.gov/pubmed/28785396 http://dx.doi.org/10.1186/s13229-017-0157-5 |
Ejemplares similares
-
Identification of a β-Arrestin 2 Mutation Related to Autism by Whole-Exome Sequencing
por: Tang, Yunfei, et al.
Publicado: (2020) -
Rett mutations attenuate phase separation of MeCP2
por: Fan, Chunyan, et al.
Publicado: (2020) -
Mutation discovery in mice by whole exome sequencing
por: Fairfield, Heather, et al.
Publicado: (2011) -
Pathway Mutations in Breast Cancer Using Whole-Exome Sequencing
por: Chang, Ya-Sian, et al.
Publicado: (2020) -
Identification of Novel EXT Mutations in Patients with Hereditary Multiple Exostoses Using Whole‐Exome Sequencing
por: Liang, Chao, et al.
Publicado: (2020)